Article

Failure of ursodeoxycholic acid to dissolve radiolucent gallstones in patients with cystic fibrosis.

Department of Pediatrics, Ospedale San Paolo, University of Milan, Italy.
Acta Paediatrica (Impact Factor: 1.84). 06/1993; 82(6-7):562-5. DOI: 10.1111/j.1651-2227.1993.tb12754.x
Source: PubMed

ABSTRACT Ursodeoxycholic acid has been used widely to dissolve cholesterol gallstones and more recently was shown to improve clinical symptoms and biochemical indices in different chronic liver diseases, including that associated with cystic fibrosis. We treated 10 cystic fibrosis patients (5 males, 5 females, age range 2-22 years) with pancreatic insufficiency and normal liver function with ursodeoxycholic acid 15-20 mg/kg/day. Seven patients had radiolucent gallstones (in 3 cases associated with biliary sludge) and 3 had sludge; all were asymptomatic. Before treatment, the gallbladder was well opacified in oral cholecystogram. The gallbladder was scanned by ultrasound in similar conditions and by the same operator before administration of ursodeoxycholic acid and after a median period of treatment of 16 months (range 11-32 months). During treatment, all patients remained asymptomatic and the relative proportion of ursodeoxycholic acid in duodenal bile increased from 4.7 +/- 3.2% at baseline to 34.7 +/- 8.6%. Complete or partial dissolution of gallstones was never observed and the maximum diameter of stones increased from a mean of 6.1 +/- 3.4 to 8.0 +/- 5.3 mm; in one case the development of biliary sludge occurred during bile acid therapy. Sludge disappeared in 1 of the 6 patients who initially had it, while in 2 cases its volume increased. We conclude that ursodeoxycholic acid is not effective in most CF patients with gallstones, probably because cholesterol is not the main component of stone or sludge.

0 Bookmarks
 · 
76 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Bile acids are natural detergents and the end-products of cholesterol metabolism. Their functions are mostly digestive: induction of bile flow and solubilization of biliary and alimentary lipids. They circulate along the enterohepatic cycle, and probably also along a shorter route, the cholehepatic shunt. They are relatively hydrophobic and perpetuate or worsen the hepatic lesions when their excretion is impaired in cholestasis, because of their affinity for biological membranes. Their functions depend on their relative hydrophilicity and ionization, ie on their structure and state of conjugation. They have an immunosuppressive effect in vivo and in vitro. Ursodeoxycholic acid (UDC) is a hydrophilic bile acid used in chronic cholestatic diseases. Biological improvement has been proven in autoimmune cholangiopathies in adults, and cystic fibrosis-associated liver disease in children. Clinical studies are on the way for other indications. It is still too early to evaluate the long-term clinical benefits, eg the reduction in needs for liver transplantation. UDC acid may induce a bicarbonate-rich hypercholerecis through the cholehepatic shunt, that would explain its efficacy in cystic fibrosis. In disorders of bile acid synthesis or transport, it could shunt the enzymatic block, or reestablish the bile flow through its osmotic effect. Like other bile acids it interacts with membranes, and is thought to stabilize them. In chronic cholestasis it would the protect the membranes against the adverse effect of non-excreted endogenous bile acids. This interaction can also explain its immunosuppressive effect, through non-specific inhibition of transmission at the cell surface. That would explain the preferential clinical efficacy of UDC in autoimmune cholestasis, and stimulate its evaluation in “immunological” indications, such as liver transplantation and hepatic graft versus host disease.
    Archives de Pédiatrie 12/1995; 2(12). DOI:10.1016/0929-693X(96)89923-4 · 0.41 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate children with gallstone in respect to demographic features, type of presentation, predisposing risk factors, laboratory features, complications, and outcome. Materials and Methods: Overall, 124 children with sonographically diagnosed gallstone were stratified into group 1 (symptomatic) and group 2 (asymptomatic). The data on demographic features, predisposing risk factors, laboratory features, complications, and outcome were collected from medical charts and compared by using convenient statistical methods.
    The Turkish journal of gastroenterology: the official journal of Turkish Society of Gastroenterology 02/2014; 25(1):46-53. DOI:10.5152/tjg.2014.3907 · 0.47 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: In the last years following the extensive use of ultrasound scanning an increasing number of children with cholelithiasis has been identified. Prevalence of cholelithiasis has been well reported , and frequency of cholecystectomy had been addressed by some investigators. The aim of our retrospective study was to evaluate the management of children with cholelithiasis observed at the Pediatric and Surgical unit linked to the Maternity and Child Teaching Hospital. Patients and Methods: The records of all patients below age of 14 years, undergoing cholecystectomy for cholelithiasis, at Maternity and Child Teaching Hospital in Al-Qadisiya governorate in Iraq, from January 2005 to December 2008 were reviewed. A total of 13 pediatric patients were included in this study. Results: Participants had a mean age of 5.6 years (SD, 2.9 years; range, 2.5-13) . There were 9 female and 4 male patients. Diagnosis of cholelithiasis was performed in all patients by ultrasound exam. All patients underwent cholecystectomy and extensive evaluations for their abdominal pain. The cause for gallbladder disease was identified as personal and familial anamnesis in 4 patients (30.7%). Intra-and post-surgery course was adequate in all patients, but 2 who had transient complications. In our experience, approach to patients with gallbladder stones was heterogeneous suggesting the need for a common protocol. However, our data show that etiology, sex incidence, diagnosis s modality and management of pediatric patients with gallbladder stones is comparable to previous reported casistics. Conclusion: Pediatricians and pediatric surgeons have to consider that cholelithiasis can occur in children. Common diagnostic, therapeutic and follow-up protocols are needed to improve our knowledge on this pediatric disease. The N Iraqi J Med August 2010; 6(2): 31 -35
    New Iraqi Journal of Medicine 08/2010; 6(2)(August 2010):31 -35.